2019

英文原著

  1. 1.Chihara A, Tanaka A, Morimoto T, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Ueda S, Node K. Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: A secondary analysis of the REASON trial. Cardiovasc Diabetol 2019;18:158 pubmed
  2. 2.Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama J-r, Lei X-F, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M. Toll-like receptor 9 plays a pivotal role in angiotensin II-induced atherosclerosis. J Am Heart Assoc 2019;8:e010860. pubmed
  3. 3.Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep 2019;9:2813. pubmed
  4. 4.Hokama N, Shirakura T, Sunagawa S, Morishima S, Nakachi S, Nishi Y, Murayama Y, Matsui C, Hase N, Tamura M, Okamoto S, Shimabukuro M, Nakamura K, Masuzaki H. A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly-sensitive assay. Hematol Oncol 2019;37:527-530 pubmed
  5. 5.Kudo A. Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population. Sci Rep 2019;9:8210. pubmed
  6. 6.Millman J, Okamoto S, Kimura A, Uema T, Higa M, Yonamine M, Namba T, Ogata E, Yamazaki S, Shimabukuro M, Tsutsui M, Matsushita M, Ikematsu S, Masuzaki H. Metabolically and immunologically beneficial impact of extra virgin olive and flaxseed oils on composition of gut microbiota in mice. Eur J Nutr 2019;59:2411-2425 pubmed
  7. 7.Morimoto T, Sakuma M, Tokushige A, Natsuaki M, Asahi T, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial. Sci Rep 2019;9:8537. pubmed
  8. 8.Nakajima A, Tanaka K, Saito H, Iwasaki T, Oda A, Kanno M, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Blood pressure control in chronic kidney disease according to underlying renal disease: The Fukushima CKD Cohort. Clin Exp Nephrol 2019;24:427-43 pubmed
  9. 9.Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.Rivaroxaban, a specific Fxa inhibitor, improved endotheliumdependent relaxation of aortic segments in diabetic mice. Sci Rep2019:9;11206 pubmed
  10. 10.Sugasawa N, Katagi A, Kurobe H, Nakayama T, Nishio C, Takumi H, Higashiguchi F, Aihara KI, Shimabukuro M, Sata M, Kitagawa T. Inhibition of atherosclerotic plaque development by oral administration of alpha-glucosyl hesperidin and water-dispersible hesperetin in apolipoprotein E knockout mice. J Am Coll Nutr 2019;38:15-22. pubmed
  11. 11.Sunagawa S, Shirakura T, Hokama N, Kozuka C, Yanamine M, Namba T, Morishima S, Nakachi S, Nishi Y, Ikema T, Okamoto S, Matsui C, Hase N, Tamura M, Shimabukuro M, Masuzaki H. Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in Japanese patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study. J Diabetes Investig 2019;10:94-103. pubmed
  12. 12.Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima K, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K. Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular diseases: results from the multicenter, randomized, placebo-controlled, double-blind EMBLEM trial. Diabetes Care 2019;42:e159-e161 pubmed
  13. 13.Yagi S, Kondo T, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata I, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M. Association of decreased docosahexaenoic acid level after statin therapy and low eicosapentaenoic acid level with in-stent restenosis in patients with acute coronary syndrome. J Atheroscler Thromb 2019;26:272-281. pubmed
  14. 14.Yamaguchi S, Abe M, Arasaki O, Shimabukuro M, Ueda S. A prognostic impact of concentric left ventricular structure observed by transthoracic echocardiography in patients with acute decompensated heart failure: a retrospective study. Int J Cardiol 2019;287:73-80. pubmed
  15. 15.Yamaguchi S, Abe M, Arasaki O, Shimabukuro M. The incremental prognostic value of platelet count in patients with acute heart failure: a retrospective observational study. Circ J 2019;83:576-583. pubmed
  16. 16.Yamaguch S, Shimabukuro M, Abe M, Arakaki T, Arasaki O, Ueda S. Comparison of the prognostic values of three calculation methods for echocardiographic relative wall thickness in acute decompensated heart failure. Cardiovasc Ultrasound 2019;17:30. pubmed

英文総説

和文著書

和文総説

国際学会

ESC Congress 2019 together with World Congress of Cardiology, Paris, France, 31 August - 04 September 2019

The 2nd Surabaya International Health Conference (SIHC 2019), Surabaya, Indonesia, 13-14 July, 2019

The 7th International Conference on Food Factors (ICoFF2019), Kobe, 01-05 December 2019

国内学会

第53回 糖尿病学の進歩(青森:2019年3月1日-2日)

第83回循環器学会学術集会(横浜:2019年3月29日-31日))

Anagliptin and Sitagliptin on LDL- cholesterol in Type 2 Diabetic Patients with Dys- lipidemia and Cardiovascular Risk Results from Reason Trial

第116回日本内科学会総会(名古屋:2019年4月26日-28日)

第56回日本臨床分子医学会学術集会(名古屋:2019年4月26-27日)

第4回血管不全学会学術集会・総会(名古屋:2019年4月29日)

第92回日本内分泌学会学術総会(仙台:2019年5月9日-11日)

第62回日本糖尿病学会年次学術集会(仙台:2019年5月23日-25日)

第19回日本日本抗加齢医学会総会(横浜:2019年6月14日-16日)

第51回日本動脈硬化学会(京都:2019年7月11日-12日)

第39回日本内分泌学会東北地方会 (福島:2019年10月19日)

第25回 日本糖尿病学会 東北地方会(仙台:2019年11月2日)

第40回日本肥満学会・第37回日本肥満症治療学会学術集会(東京:2019年11月2-3日)

ページの先頭へ戻る